David Shaw’s GSK GSK Stock Holding History

David Shaw’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.49M	Buy	66,600 +37,500	+129%	+$1.98M	﹤0.01%	2706
2026 Q1	$1.61M	Buy	+29,100	New	+$1.58M	﹤0.01%	3090
2025 Q2	–	Sell	-102,700	Closed	-$3.98M	–	4482
2025 Q1	$3.98M	Buy	+102,700	New	+$3.76M	﹤0.01%	2072
2021 Q2	–	Sell	-40,000	Closed	-$1.78M	–	4849
2021 Q1	$1.78M	Buy	+40,000	New	+$1.82M	﹤0.01%	2681
2019 Q1	–	Sell	-10,160	Closed	-$485K	–	3718
2018 Q4	$485K	Hold	10,160	–	–	﹤0.01%	3104
2018 Q3	$510K	Hold	10,160	–	–	﹤0.01%	3103
2018 Q2	$512K	Sell	10,160 -24,000	-70%	-$1.21M	﹤0.01%	3105
2018 Q1	$1.67M	Buy	34,160 +10,160	+42%	+$473K	﹤0.01%	2169
2017 Q4	$1.06M	Buy	+24,000	New	+$1.11M	﹤0.01%	2544
2016 Q2	–	Sell	-24,720	Closed	-$1.25M	–	3398
2016 Q1	$1.25M	Hold	24,720	–	–	﹤0.01%	2209
2015 Q4	$1.25M	Buy	+24,720	New	+$1.26M	﹤0.01%	2493

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

David Shaw's GSK Position: Q2 2026 in Review

David Shaw opened a new position in GSK (GSK) in Q2 2026: 1,019,449 shares worth $53.4M. The stake represents 0.03% of the portfolio and ranks #726 among its holdings. This is a return to the name: David Shaw previously reported a position in GSK as recently as Q4 2025.

David Shaw first reported a position in GSK in Q2 2013 and has held it in 30 quarters since. The position peaked at $81.6M in Q2 2015. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

David Shaw held 1,019,449 shares of GSK worth $53.4M as of Q2 2026.
GSK was a new David Shaw position in Q2 2026.
GSK made up 0.03% of David Shaw's portfolio in Q2 2026, its #726 holding.
David Shaw first reported a position in GSK in Q2 2013 and has held it in 30 quarters since.
David Shaw's GSK position peaked at $81.6M in Q2 2015.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.